The gut microbiota plays a critical role in the pathogenesis of inflammatory bowel diseases (IBD), including both Crohn’s disease and ulcerative colitis, driving growing interest in therapies that target gut microbes as adjunctive or primary treatment. Among these, fecal microbiota transplantation (FMT) has attracted attention due to its remarkable success Clostridioides difficile infection1 and promising […]
